Regulatory obstacles to the development of the market for biogeneric drugs are falling down, and the first products are set to reach the markets of North America and Europe in 2006-7, according to consulting firm Frost & Sullivan.
The markets in Europe and the US alone have the potential to generate sales of $16.39 billion by 2011, according to the company.
yeah, but will this generate any work???...
link from in-pharmatech.com
Wednesday, September 07, 2005
Biogenerics market set to explode?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment